- Home
- SPRB vs EKSO Comparison
SPRB vs EKSO Comparison
Compare SPRB & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRB
- EKSO
- Stock Information
- Founded
- SPRB 2014
- EKSO 2005
- Country
- SPRB United States
- EKSO United States
- Employees
- SPRB N/A
- EKSO N/A
- Industry
- SPRB Medicinal Chemicals and Botanical Products
- EKSO Medical/Dental Instruments
- Sector
- SPRB Health Care
- EKSO Health Care
- Exchange
- SPRB Nasdaq
- EKSO Nasdaq
- Market Cap
- SPRB 15.7M
- EKSO 13.4M
- IPO Year
- SPRB 2020
- EKSO N/A
- Fundamental
- Price
- SPRB $0.42
- EKSO $0.55
- Analyst Decision
- SPRB Hold
- EKSO Strong Buy
- Analyst Count
- SPRB 7
- EKSO 2
- Target Price
- SPRB $2.17
- EKSO $5.50
- AVG Volume (30 Days)
- SPRB 417.1K
- EKSO 318.5K
- Earning Date
- SPRB 03-12-2025
- EKSO 03-03-2025
- Dividend Yield
- SPRB N/A
- EKSO N/A
- EPS Growth
- SPRB N/A
- EKSO N/A
- EPS
- SPRB N/A
- EKSO N/A
- Revenue
- SPRB $7,101,000.00
- EKSO $17,682,000.00
- Revenue This Year
- SPRB N/A
- EKSO N/A
- Revenue Next Year
- SPRB N/A
- EKSO $32.74
- P/E Ratio
- SPRB N/A
- EKSO N/A
- Revenue Growth
- SPRB N/A
- EKSO 4.12
- 52 Week Low
- SPRB $0.34
- EKSO $0.47
- 52 Week High
- SPRB $5.95
- EKSO $2.16
- Technical
- Relative Strength Index (RSI)
- SPRB 58.94
- EKSO 42.05
- Support Level
- SPRB $0.38
- EKSO $0.50
- Resistance Level
- SPRB $0.42
- EKSO $0.61
- Average True Range (ATR)
- SPRB 0.03
- EKSO 0.04
- MACD
- SPRB 0.00
- EKSO 0.00
- Stochastic Oscillator
- SPRB 69.77
- EKSO 57.33
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.